The abstract is read at the publisher; the summary is JClub's.
In humans and ferrets, AT2-independent routes from terminal and proximal airway subsets to AT1 cells operate, unlike in mice or swine, and are validated in organoid and xenograft models.
- Why it matters: Curative lung therapies are limited, and the field lacks clear, human-relevant maps of how AT1 cells regenerate after severe injury versus disease.
- What they did: The team used computational inference to identify AT2-independent trajectories, then validated them in human organoids and in human-rat xenografts, and tested disruption patterns across disease contexts.
- The result: Disease-specific disruption links these routes to a TGFbeta- and Hippo-regulated physiological equivalent of profibrotic aberrant basaloid cells, implying that model choice must match human repair biology.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.